Literature DB >> 7850266

Allogeneic marrow transplantation for chronic myeloid leukemia.

F R Applebaum1, R Clift, C D Buckner, C Anasetti, J Radich, T Higano, R Storb, J Hansen, E D Thomas.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7850266     DOI： 10.1007/bf02988833

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  9 in total

1.  Indications for marrow transplantation in chronic myelogenous leukemia.

Authors:  E D Thomas; R A Clift
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

2.  Marrow transplantation for the treatment of chronic myelogenous leukemia.

Authors:  E D Thomas; R A Clift; A Fefer; F R Appelbaum; P Beatty; W I Bensinger; C D Buckner; M A Cheever; H J Deeg; K Doney
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

Review 3.  Treatment of chronic myeloid leukemia by marrow transplantation.

Authors:  R A Clift; F R Appelbaum; E D Thomas
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

4.  Graft-versus-leukemia: no longer an epiphenomenon.

Authors:  J H Antin
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

5.  Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

Authors:  M S Roth; J H Antin; E L Bingham; D Ginsburg
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

6.  Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase.

Authors:  J M Goldman; R Szydlo; M M Horowitz; R P Gale; R C Ash; K Atkinson; K A Dicke; E Gluckman; R H Herzig; A Marmont
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

7.  Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.

Authors:  R Delage; R J Soiffer; K Dear; J Ritz
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

Review 8.  High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.

Authors:  K G Blume; S J Forman
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

9.  Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.

Authors:  P McGlave; G Bartsch; C Anasetti; R Ash; P Beatty; J Gajewski; N A Kernan
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113
  9 in total
  1 in total

Review 1.  Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. I: Clinical applications and therapeutic effects.

Authors:  T D Miale; S Sirithorn; S Ahmed
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.